Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9856327 Heterodimeric antibodies to CD3 X CD123

Patent 9856327 was granted and assigned to Xencor on January, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rumana Rashid0

Gregory Moore0

John Desjarlais0

Matthew J. Bernett0

Seung Chu0

Sung-Hyung Lee0

Umesh Muchhal0

Date of Patent

January 2, 2018

0

Patent Application Number

151861670

Date Filed

June 17, 2016

0

Patent Citations Received

US Patent 11939392 CD123 binding proteins and related compositions and methods

0

US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38

0

0

US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

0

US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

0

US Patent 11884720 Antibody constructs for MSLN and CD3

0

US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens

0

US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3

0

...

Patent Primary Examiner

0

Patent abstract

The present invention is directed to novel heterodimeric antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9856327 Heterodimeric antibodies to CD3 X CD123

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool